Patient Guide: Study to Evaluate Adverse Events, Change in Disease Activity, and How Oral ABBV-101 Moves Through the Body in Adult Participants With B-Cell Malignancies

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 49 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT05753501
Status: 🟢 Enrolling Now
Condition: Hematologic Cancer
Phase: PHASE1

Where You Can Participate

This study is available at 49 locations across the country.

Top locations include:
  • • Tempe, Arizona
  • • Orange, California
  • • Palo Alto, California
  • • And 46 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Study to Evaluate Adverse Events, Change in Disease Activity, and How Oral ABBV-101 Moves Through the Body in Adult Participants With B-Cell Malignancies - Join Clinical Trial NCTNCT05753501

How to Join This Clinical Trial - NCTNCT05753501

Learn how to participate in this PHASE1 trial studying an investigational therapy for Hematologic Cancer. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Hematologic Cancer. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Hematologic Cancer
Treatment Being Tested
Investigational treatment
Study Phase
PHASE1 - Early safety study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT05753501 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 49 locations. Find a study site near you:

Clinical Research Site

Tempe, Arizona 85284-1812 - United States

Status: RECRUITING

Clinical Research Site

Orange, California 92868-3201 - United States

Status: RECRUITING

Clinical Research Site

Palo Alto, California 94304 - United States

Status: RECRUITING

Clinical Research Site

Lone Tree, Colorado 80124 - United States

Status: RECRUITING

Clinical Research Site

Chicago, Illinois 60611-2927 - United States

Status: RECRUITING

Clinical Research Site

Boston, Massachusetts 02215-5400 - United States

Status: RECRUITING

Clinical Research Site

New Brunswick, New Jersey 08901 - United States

Status: RECRUITING

Clinical Research Site

Albany, New York 12206-5013 - United States

Status: COMPLETED

Clinical Research Site

Lake Success, New York 11042 - United States

Status: RECRUITING

Clinical Research Site

Rochester, New York 14642-0001 - United States

Status: RECRUITING

And 39 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE1 clinical trial for Hematologic Cancer:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships